12:00 AM
Apr 29, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Hexyon/Hexacima regulatory update

The European Commission approved an MAA from Sanofi for its Hexyon/Hexacima vaccine for primary and booster vaccination against diphtheria, tetanus, pertussis, hepatitis B, polio and Haemophilus influenzae type b (Hib) in infants and toddlers...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >